IGF2 and experimental autoimmune encephalomyelitis: Recent studies have shown that IGF2 alleviated experimental autoimmune encephalomyelitis (EAE) and dextran sodium sulfate (DSS)-induced colitis by programming macrophages to acquire an alternatively activated phenotype 70, 71.